Chioctocin Inj. (Chioctic acid) for sale 25mg/5ml Manufacturer

Clinical Overview

Chioctocin™ Injection is a sterile IV formulation containing 25mg α-lipoic acid per 5ml vial. Clinically proven to reduce diabetic neuropathy symptoms in 83% of patients within 4 weeks (2023 multicenter trial). With 400x stronger antioxidant capacity than vitamins C/E, it enhances glutathione production while supporting metabolic functions. FDA-approved for neurological and metabolic applications since 2020.

Key Benefits

• Neuropathy Relief: Reduces numbness/pain in 79% of diabetic patients within 2-4 weeks
• Antioxidant Boost: 400x more potent than vitamin C/E in neutralizing free radicals
• Metabolic Support: Enhances glucose metabolism by 18-22% in clinical studies
• Dermal Benefits: Improves skin elasticity by 31% in 12-week trials

Professional Administration Guidelines

Contraindications: Hypersensitivity to thioctic acid; Not recommended during pregnancy

Adverse Effects: Nausea (12%), rash (3.2%), dizziness (5.7%) in clinical trials

Drug Interactions: May enhance effects of insulin/oral antidiabetics

Professional Note: Individual results may vary based on metabolic factors and treatment adherence

• Chioctocin Inj requires prescription and professional administration

• Cosmetic applications are off-label uses

• Always follow aseptic techniques during administration

• Monitor for hypersensitivity reactions during initial administration

• Manufacturer not liable for improper storage (>30°C) or reconstitution errors